Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02892422 · ClinicalTrials.gov registry record · Phase 3
Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia
A Phase 3 study, sponsored by H. Lundbeck A/S.
- Completed
- Registry status
- Phase 3
- Development phase
- 528
- Enrollment target
NCT02892422: Completed Phase 3 study, sponsored by H. Lundbeck A/S.
NCT02892422 is a Phase 3 study that has completed, run by H. Lundbeck A/S. The registered enrollment target is 528 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02892422, a Phase 3 study, has completed, sponsored by H. Lundbeck A/S.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 528 participants
- Enrollment target
Study Summary
To evaluate the safety and tolerability of the long-term treatment with Lu AF35700.
Primary Outcome
Based on the safety assessments (e.g. clinical safety laboratory tests, vital signs, weight, waist circumference and ECG)
Interventions
- DRUG Lu AF35700
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 528 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-10-10 |
| Phase | Phase 3 |
What the finished NCT02892422 record still lists
NCT02892422 is an interventional study that assigns participants to a tested intervention. The registered 528 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 1 intervention - of which Lu AF35700 is the first listed.
NCT02892422 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02892422 about?
NCT02892422 is a clinical study titled "Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia". To evaluate the safety and tolerability of the long-term treatment with Lu AF35700.
What is the current status of trial NCT02892422?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 528 participants. The study started on 2016-08. Estimated completion is 2019-10-10.
What interventions are being tested in trial NCT02892422?
The interventions under investigation include: Lu AF35700 (DRUG).
Who is sponsoring clinical trial NCT02892422?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02892422's enrollment target sits among peer trials
528 711th of 2000 higher than 1,286 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373017 · 528 participants · NA
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
- NCT05634252 · 528 participants · Phase 3
Undergraduate Skin Cancer Prevention Trial
- NCT06383273 · 528 participants · Phase 3
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
- NCT06470243 · 528 participants · Phase 3
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia